## 4 Discussion  
This pilot study explored the potential effects of UEVT-WBV on upper extremity function in children with CP. This study's primary focus was to assess feasibility and \begin{table}
\begin{tabular}{l l l l} \hline \hline
**Subscales Quality-of-Life** & **Assessment Time Points** & **Study Groups** & **Interaction: Time** \\
**Questionnaire for Children** & **(df = 2)** & **(df = 1)** & **Points \(\times\) Groups** \\ \hline General Quality of Life in Children & \(p\) = 0.71 & \(p\) = 0.86 & \(p\) = 0.13 \\ \hline Social Well-being and Acceptance & \(p\) = 0.92 & \(p\) = 0.28 & \(p\) = 0.86 \\ \hline Feelings About Child Functionality & \(p\) = 0.36 & \(p\) = 0.35 & \(p\) = 0.42 \\ \hline Physical Health and Participation & \(p\) = 0.93 & \(p\) = 0.81 & \(p\) = 0.45 \\ \hline Emotional Well-being and Self-Esteem & \(p\) = 0.40 & \(p\) = 0.26 & \(p\) = 0.94 \\ \hline Access to Services for Children & \(p\) = 0.26 & \(p\) = 0.56 & \(p\) = 0.26 \\ \hline Pain and Impact on Disability & \(p\) = 0.65 & \(p\) = 0.56 & \(p\) = 0.98 \\ \hline Family Health of Children & \(p\) = 0.78 & \(p\) = 0.55 & \(p\) = 0.64 \\ \hline \hline \end{tabular}
\end{table} 
Table 6: A summary of \(p\) values from comparative analysis of the quality-of-life questionnaire for children subscales, comparing the intervention and control groups across three time points (baseline, 4 th intervention week, and 8 th intervention week). \begin{table}
\begin{tabular}{l l l l} \hline \hline
**Subscales Quality-of-Life** & **Baseline (Total)** & **Intervention Group** & **Control Group** \\
**Questionnaire for Children** & **(Mean \(\pm\) SD)** & **(Mean \(\pm\) SD)** & **(Mean \(\pm\) SD)** \\ \hline General Quality of Life in Children & 70.22 \(\pm\) 3.42 & 71.24 \(\pm\) 2.143 & 69.46 \(\pm\) 4.315 \\ \hline Social Well-being and Acceptance & 89.28 \(\pm\) 5.97 & 87.15 \(\pm\) 6.69 & 90.88 \(\pm\) 5.79 \\ \hline Feelings About Child Functionality & 77.38 \(\pm\) 9.72 & 82.29 \(\pm\) 4.77 & 73.69 \(\pm\) 11.48 \\ \hline Physical Health and Participation & 73.57 \(\pm\) 9.72 & 76.25 \(\pm\) 12.31 & 71.56 \(\pm\) 8.68 \\ \hline Emotional Well-being and Self-Esteem & 85.41 \(\pm\) 9.99 & 92.36 \(\pm\) 3.18 & 80.20 \(\pm\) 10.41 \\ \hline Access to Services for Children & 63.11 \(\pm\) 9.99 & 59.58 \(\pm\) 10.18 & 66.11 \(\pm\) 5.83 \\ \hline Pain and Impact on Disability & 28.50 \(\pm\) 19.49 & 22.92 \(\pm\) 9.02 & 32.91 \(\pm\) 25.52 \\ \hline Family Health of Children & 75.00 \(\pm\) 3.12 & 78.12 \(\pm\) 19.00 & 71.09 \(\pm\) 10.32 \\ \hline \hline \end{tabular}
\end{table} 
Table 5: The subscales of the quality-of-life questionnaire for children, at the baseline and after the 8 weeks of this study for the intervention and the control groups. provide preliminary insights into the intervention's utility, rather than to establish definitive therapeutic outcomes. The findings demonstrated that the intervention was well tolerated by the participants and logistically feasible within a pediatric rehabilitation setting. Both the intervention and control groups exhibited reductions in spasticity over time, as measured by the MAS, with the lowest scores observed at the end of the intervention period. These results suggest that UEVT-WBV, when combined with conventional physiotherapy, may be a viable approach for managing upper limb spasticity. However, the lack of significant differences between groups underscores the exploratory nature of this study and highlights the need for further research. Physiotherapy plays a crucial role in addressing challenges such as neuromuscular control, balance, strength, and coordination by targeting body structure and improving muscle tone in children with CP [18; 19]. These impairments often lead to gait abnormalities and difficulties in daily activities, highlighting the need for effective therapeutic protocols [1; 3].